Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Helesicova K"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
Autorzy:
Alcalay RN; Department of Neurology, Columbia University Irving Medical Center New York, New York, USA.
Wolf P; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
Chiang MSR; Rare and Neurological Diseases Therapeutic Area, Sanofi, Framingham, Massachusetts, USA.
Helesicova K; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
Zhang XK; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
Merchant K; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Hutten SJ; The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
Scherzer C; Advanced Center for Parkinson's Disease Research of Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Precision Neurology Program, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
Blauwendraat C; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
Foroud T; Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Nudelman K; Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Gan-Or Z; Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.; Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Levy O; Department of Neurology, Columbia University Irving Medical Center New York, New York, USA.
Zheng D; Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center New York, New York, USA.
Li G; Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center New York, New York, USA.
Sardi SP; Rare and Neurological Diseases Therapeutic Area, Sanofi, Framingham, Massachusetts, USA.
Pokaż więcej
Corporate Authors:
Parkinson’s Progression Markers Initiative
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Oct; Vol. 7 (10), pp. 1816-1830. Date of Electronic Publication: 2020 Sep 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Dementia/*physiopathology
Glucosylceramidase/*metabolism
Parkinson Disease/*metabolism
Parkinson Disease/*pathology
Adult ; Dementia/complications ; Dementia/pathology ; Disease Progression ; Female ; Genotype ; Glucosylceramidase/genetics ; Heterozygote ; Humans ; Male ; Mental Status and Dementia Tests ; Middle Aged ; Mutation/genetics ; Parkinson Disease/complications ; Phenotype
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies